These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31699501)

  • 21. Validation is a key theme in this issue of ALTEX.
    von Aulock S
    ALTEX; 2011; 28(1):1. PubMed ID: 21404727
    [No Abstract]   [Full Text] [Related]  

  • 22. An improved abnormal toxicity test by using reference vaccine-specific body weight curves and histopathological data for monitoring vaccine quality and safety in Japan.
    Mizukami T; Masumi A; Momose H; Kuramitsu M; Takizawa K; Naito S; Maeyama J; Furuhata K; Tsuruhara M; Hamaguchi I; Yamaguchi K
    Biologicals; 2009 Jan; 37(1):8-17. PubMed ID: 18805705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there a need in regulatory toxicity testing for evaluating chemicals at doses eliciting general toxicity?
    Chahoud I; Grote K
    Toxicology; 2016 Jul; 363-364():46-7. PubMed ID: 27430607
    [No Abstract]   [Full Text] [Related]  

  • 24. The ICLAS/CCAC International Symposium on Regulatory Testing and Animal Welfare.
    Griffin G; Stokes WS; Pakes SP; Gauthier C
    Altern Lab Anim; 2004 Jun; 32 Suppl 1B():707-12. PubMed ID: 23581164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aligning the 3Rs with new paradigms in the safety assessment of chemicals.
    Burden N; Mahony C; Müller BP; Terry C; Westmoreland C; Kimber I
    Toxicology; 2015 Apr; 330():62-6. PubMed ID: 25932488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drivers and barriers in the consistency approach for vaccine batch release testing: Report of an international workshop.
    Bruysters MWP; Schiffelers MJ; Hoonakker M; Jungbaeck C; Ragan I; Rommel E; van der Stappen T; Viviani L; Hessel EV; Akkermans AM; Vandebriel RJ
    Biologicals; 2017 Jul; 48():1-5. PubMed ID: 28666717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory forum opinion piece*: supporting the need for international harmonization of safety assessments for food flavoring substances.
    Konishi Y; Hayashi SM; Fukushima S
    Toxicol Pathol; 2014 Aug; 42(6):949-53. PubMed ID: 23881932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consensus report on the future of animal-free systemic toxicity testing.
    Leist M; Hasiwa N; Rovida C; Daneshian M; Basketter D; Kimber I; Clewell H; Gocht T; Goldberg A; Busquet F; Rossi AM; Schwarz M; Stephens M; Taalman R; Knudsen TB; McKim J; Harris G; Pamies D; Hartung T
    ALTEX; 2014; 31(3):341-56. PubMed ID: 25061899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of animal use in human vaccine quality control: opportunities and problems.
    Metz B; Hendriksen CF; Jiskoot W; Kersten GF
    Vaccine; 2002 Jun; 20(19-20):2411-30. PubMed ID: 12057596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternatives to the use of animals in R & D and quality control of veterinary vaccines: an industry view.
    Verschueren C; Zänker S
    Dev Biol Stand; 1996; 86():49-51. PubMed ID: 8785991
    [No Abstract]   [Full Text] [Related]  

  • 31. Food for thought ... on validation. A puzzle or a mystery: an approach founded on new science.
    Wilcox N; Goldberg A
    ALTEX; 2011; 28(1):3-8. PubMed ID: 21311846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steps towards the international regulatory acceptance of non-animal methodology in safety assessment.
    Sewell F; Doe J; Gellatly N; Ragan I; Burden N
    Regul Toxicol Pharmacol; 2017 Oct; 89():50-56. PubMed ID: 28689746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards an integrated in vitro strategy for repeated dose toxicity testing.
    Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
    Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
    [No Abstract]   [Full Text] [Related]  

  • 34. International regulatory requirements for Leptospira vaccine potency testing. Roundtable: current requirements and opportunity for harmonization.
    Draayer HA; Bruckner L; Peña-Moctezuma Ade L; Srinivas G
    Biologicals; 2013 Sep; 41(5):305-7. PubMed ID: 23890730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Batch safety testing of veterinary vaccines - potential welfare implications of injection volumes.
    Cooper J
    Altern Lab Anim; 2008 Dec; 36(6):685-94. PubMed ID: 19154094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refinement, reduction, and replacement of animal use for regulatory testing: current best scientific practices for the evaluation of safety and potency of biologicals.
    Hendriksen CF
    ILAR J; 2002; 43 Suppl():S43-8. PubMed ID: 12388851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals.
    Lilley E; Isbrucker R; Ragan I; Holmes A
    Biologicals; 2021 Nov; 74():24-27. PubMed ID: 34750045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop.
    Ramirez T; Beken S; Chlebus M; Ellis G; Griesinger C; De Jonghe S; Manou I; Mehling A; Reisinger K; Rossi LH; van Benthem J; van der Laan JW; Weissenhorn R; Sauer UG
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):210-26. PubMed ID: 26188116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The five Rs: refinement, reduction, replacement. A regulatory revolution.
    Lucken RN
    Dev Biol Stand; 1996; 86():67-72. PubMed ID: 8785993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bridging the gap between regulatory acceptance and industry use of non-animal methods.
    Clippinger AJ; Hill E; Curren R; Bishop P
    ALTEX; 2016; 33(4):453-458. PubMed ID: 27254273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.